Milim - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Milim

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

European Journal of Cancer (Oxford, England : 1990)|October 27, 2023

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.

Free Radical Biology & Medicine|September 17, 2016

Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisDa Hyun Lee, Dai Hoon Han, Ki Taek Nam, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025

Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancerSeung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, et al.

Nature Communications|May 18, 2024

Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancerByungsoo Ahn, Damin Moon, Hyun-Soo Kim, et al.

Pageof 7

Search research articles

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

European Journal of Cancer (Oxford, England : 1990)|October 27, 2023

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.

Free Radical Biology & Medicine|September 17, 2016

Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisDa Hyun Lee, Dai Hoon Han, Ki Taek Nam, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025

Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancerSeung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, et al.

Nature Communications|May 18, 2024

Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancerByungsoo Ahn, Damin Moon, Hyun-Soo Kim, et al.

Pageof 7